Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pre-reg Material > Cardiovascular System > Flashcards

Cardiovascular System Flashcards

1
Q

Management of ectopic beats

A

Spontaneous
- beta blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Managing life-threatening AF

A

Emergency electrical cardioversion
Without delay to achieve anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Managing AF without life threading haemodynamic instability

A

RATE OR RHYTHM control
Less than 48 hours = either
More than 48 hours or uncertain = rate control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug used for urgent rate control

A

IV beta blocker
Verapamil - if left ventricular ejection fraction is >40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When to avoid CCB in AF

A

Patients with suspected concomitant acute decompensated HF.
Seek advice from a specialist for the use of BB.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ways of rhythm control

A
  1. Electrical cardioversion
  2. Pharmacological cardioversion - flecanide or amiodarone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When do you avoid flecanide?

A

Known structural or ischaemic heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Electrical cardioversion is preferred to pharmacological cardioversion. If it’s been more than 48 hours then electrical cardioversion is preferable but should be avoided until the patient is fully anticoagulated. Why? And how?

A

Why?
To make sure there’s not atrial thrombus.

How?
Coagulate the patient for 3 weeks before.
- If not possible then rule out left atrial thrombus and start the patient on parenteral heparin before.
- electrical cardioversion
- oral anticoagulation with amiodarone for 4 weeks after.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rhythm control is preferred in 5 types of people?

A
  1. New onset AF
  2. Atrial flutter suitable for ablation strategy
  3. AF with a reversible cause
  4. Heart failure caused by AF
  5. Rhythm control is more suitable based on clinical judgement.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management options for AF

A

Step wise approach.
1st line - Rate control
- standard BB
- diltiazem
- verapamil monotherapy
- digoxin - primarily sedentary

2nd line - combination with two drugs - not verapamil
- if ventricular rate is diminished LVEF < 40%
(BB licensed in HF With digoxin)

3rd line - anti-arrhythmic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Need to prevent stroke in patients with AF. How?

A

Cha2Ds2Vas for stroke risk
Congestive heart failure
Hypertension
Age > 75
Diabetes
Stroke (previous) / TIA/ thromboembolism
Vascular disease
Age 65-75
Sex (female)

ORBIT risk tool
Older age > 74 years
Reduced haemoglobin/ anaemia
Bleeding history
Insufficient kidney function
Treatments (other bleeding risks)

Low risk = 0-2
Medium risk = 3
High risk > 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Options for coagulation for stroke prevention?

(Who is it given to? And what’s first line/second line? What can you not give?)

A
  • offered to patients with confirmed diagnosis of AF and sinus rhythm not restored within 48 hours.
  • risk of stroke > risk of bleeding

1st line - oral anticoagulation with DOAC
2nd line - warfarin review annually

If pt already on warfarin review annually to switch to DOAC if appropriate.

Not aspirin monotherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atrial flutter

A

Control of ventricular rate is usually an interim measure pending restoration of sinus rhythm.

Direct current cardioversion is usually the treatment of choice.

Recurrent atrial flutter - catheter ablation

Flecanide or propafenone - can slow the atrial flutter resulting in 1:1 conduction. And should be given together with ventricular rate control (BB, diltiazem, verapamil or digoxin).

Assess the patient for stroke risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Arrhythmia after myocardial interaction

A

In patients with proximal tachycardia or rapid irregularity of pulse - oral anti-arrythmic but not without an ECG.

Bradycardia - IV atropine

risk of Asystole / not responded to atropine - iv infusion of adrenaline. Dose adjusted according to response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Transient ischaemic attack

A

1st line - aspirin immediately 300mg
(Can add PPI)

2nd line - clopidogrel 75mg

Secondary prevention
With long term management-
1st line - Clopidogrel 75mg
Alternative - MR dipyridamole + aspirin
- MR dipyridamole alone
- aspirin alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute ischaemic stroke treatment?

A

1st - Alteplase within 4.5 hours
2nd - start aspirin 300mg for 14 days within 24 hours of symptoms.
Alternative - clopidogrel 75mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Long-term management of stroke/TIA

A

1st option - clopidogrel 75mg
Alternative - MR dipyridamole + aspirin
- MR dipyridamole alone
- Aspirin alone

Also initiate a high intensity STATIN
(Within 48 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What do you do if the patient is taking anticoagulation for prosthetic heart valves who have an ischaemic stroke and a significant risk of haemorrhagic stroke?

A

Stop anticoagulant treatment for 7 days and substitute with aspirin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Management if intracerebral haemorrhage?

A

Initial management
- surgical intervention to remove the haematoma and relieve intracranial pressure.
(Not to give rapid BP lowering drugs to patients with Glasgow coma scale of less than 6 or an underlying structural cause or early neurosurgery).

  • Rapid blood pressure lowering in pts without any exclusions. Within 6 hours and have a systolic pressure between 150-220mmHg.
  • Aim for 140mmHg
  • not to let it drop more than 60mmHg within 1 hour.
  • those who present after 6 hours with systolic BP > 220mmHg. Consider lowering Bp on a case by case basis.

Patients taking anticoags should have treatment stopped and reversed.

Long term management
- NO aspirin
- NO statins usually
- BP drugs only if indicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lifestyle factors to reduce BP

A
  • regular exercise
  • healthy diet
  • low salt
  • reduce alcohol mistake
  • not to have excessive caffeine
  • stop smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hypertension threshold stages

A

> 140/90mmhg in clinic
Offer - ABPM/ HBPM

Stage 1 : 140/90 - 159/99
Stage 2 : 160/100 - 179/119
Severe HTN : >180/120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HTN threshold for treatment

A

Stage 1 140/90-159/99

Treat Under 80
1) Stage 1 + one of the following
- target organ damage
- established CVD
- renal disease
- diabetes
- 10 year risk > 10%
2) stage 2
3) severe HTN - promptly

Consider treatment
Under 60 and 10 year CV risk < 10%

Seek specialist advise
Under 40 with STAGE 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Same day referral

A
  • suspected phaeochromocytoma
    (Labial or postural hypotension, headache, palpitations, pallor, abdominal pain, or diaphoresis)
  • clinic BP 180/120 with signs of retinal haemorrhage, papilloedema, or life-threatening symptoms (confusion, chest pain, signs of heart failure, AKI)
  • severe HTN and no symptoms - investigate for target organ damage. If target organ damage = treat
  • severe HTN + no target organ damage + no symptoms = repeat BP within 7 days.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HTN treatment targets

A

Under 80 - 140/90
Over 80 - 150/90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

For black African / African Caribbean do you give ACEi or an ARB?

A

ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Treatment options for:
- under 55
- diabetic

A
  1. ACEi or ARB
    • CCB or thiazide-like diuretic
      (Thiazide if HF present)
  3. ACEI/ARB + CCB + Thiazide-like
  4. Option of
    - low dose spironelactone if k+ <4.5mmol/l
    - alpha blocker
    - beta blocker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Treatment options for:
- over 55 years
- black African / African Caribbean

A
  1. CCB
    • ACEi / ARB / thiazide like diuretic
  3. CCB + thiazide-like + ACEI/ARB
  4. Addition of
    - low dose spironelactone if k+ <4.5mmol/l
    - alpha blocker
    - beta blocker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

HTN in diabetes

A

Type 1 diabetes based on albumin:creatinine ratio.

Under 80 + ACR<70mg/mmol = 140/90
Under 80 + ACR>70mg/mmol = 130/80

Over 80 = 150/90mmHg

Type 2 diabetes is the same as normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

HTN in renal disease

A

Targets are based on albumin:creatinine ratio and CKD

CKD + ACR<70mg/mmol = 140/90
CKD + ACR>70mg/mmol = 130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

HTN in pregnancy
(chronic/gestational/pre-eclampsia)

A

Can be in 4 ways
1. Before pregnancy
2. Develops in the 20 weeks - chronic HTN
3. Develops after 20 weeks - gestational HTN
4. Pre-eclampsia - after 20 weeks and multi-organ involvement

Above 140/90mmHg = treat
Target if <135/85mmHg

Options
1. Oral labetolol
2. Nifedipine MR
3. Methyldopa

Above 160/110mmHg = IV immediately
1. IV labetolol
2. IV hydralazine
3. Oral nifedipine MR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Symptoms of pre-eclampsia

A
  • severe headache
  • problems with vision
  • severe pain below ribs
  • vomiting
  • sudden swelling of hands, feet and face
  • significant proteinuria
  • BP>140/90mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Aspirin for pre-eclampsia in pregnancy?

A

One or more moderate risk factors or high risk of developing pre-eclampsia. Give aspirin from 12 weeks until the baby is born.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Magnesium sulfate in pre-eclampsia

A

Give IV magnesium sulfate in women with severe HTN or severe pre-eclampsia or if they have had a previous eclamptic fit.

If birth planned in the next 24 hours and pt has severe pre-eclampsia - give IV magnesium sulfate

Females with pre-eclampsia where early birth is considered or likely in 7 days - consider antenatal corticosteroids for fetal lung maturation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Antihypertensives whilst breast-feeding

A
  1. Enalipril 1st line
  2. Amlodipine/nifedipine (black African or African Caribbean)
  3. Labetolol (option)
  4. Atenolol

If one doesn’t help. Consider combination with above.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Complication of heart failure?

A
  • CKD
  • atrial fibrillation
  • depression
  • cachexia
  • sexual dysfunction
  • sudden cardiac death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Drugs that can cause or worsen heart failure need to be stopped?

A

PAC-MAN

PIOGLITAZONE
ANTI-ARRYTHMICS
CCB
METFORMIN
ANTI-DEPRESSANTS
NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Thiazide diuretics only work in certain patients with HF. When is it okay to give?

A

eGFR > 30ml/min/1.73m2
Mild fluid retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Treatment of chronic HF with reduced ejection fraction?

A

1st line
ACEi/ARB (licensed for HF: candesartan, losartan, valsartan) + BB (licensed for HF: bisoprolol, carvedilol, nebivolol)
2nd line + spironelactone/epleronone
Symptoms persist : ADD
- amiodarone
- digoxin
- sacubitril with valsartan
- ivabradine
- empagliflozin / dapagliflozin

Option 2
Hydralazine + nitrate can be considered under the advice of a specialist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Complications that can occur due to stable angina?

A
  • stroke
  • unstable angina
  • MI
  • sudden cardiac death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is prinzmetals or vasopastic angina?

A

Rare form of angina, caused by a narrowing or occlusion of proximal coronary arteries due to spasm. Pain is experienced at rest rather than during activities.

41
Q

Treatment of an acute attack of angina?

A

Sublingual GTN.

Can also be used as preventative before performing activities that bring on an attack.

42
Q

Treatment of stable angina?
Preventative

A

1st line
Beta-blocker

Alternative
CCB - rate limiting - diltiazem/verapamil

2nd line
- Combination of BB + CCB (diltiazem)
- can also combine CCB/BB with one of the following options:
1) long acting nitrate
2) ivabradine
3) nicorandil
4) ranolazine
(These drugs can also be used alone if both CCB and BB’s are contr-indicated)

Non-drug treatment
Revascularisation - coronary artery bypass graft / percutaneous coronary intervention.

43
Q

Secondary prevention of cardiovascular events in patients with angina?

A
  • low dose aspirin
  • statin
  • ACEi if patients also diabetic
44
Q

Unstable angina and NSTEMI

A
45
Q

STEMI

A
46
Q

Secondary prevention of ACS/cardiovascular events

A
47
Q

Amiodarone
- loading dose
- side-effects
- monitoring
- pregnancy

A

Loading dose
200mg TDS for 1 week, 200mg BD for 1 week then 200mg OD.

Side effects
1. Corneal micro-deposition
2. Thyroid function
3. Hepatotoxicity - treatment discontinued if severe liver abnormalities or signs of liver damage
4. Pulmonary toxicity - new progressive shortness of breath or cough = pneumonitis
5. Phototoxicity

Monitoring
- TFTs before then every 6 months
- LFTs before then every 6 months
- serum K - before
- chest x-ray - before
- with IV USE - ECG and resuscitation facilities should be available

Pregnancy
Use only if no alternatives
Possible neonatal goitre

48
Q

Sotalol

A
  • Prolongs the Qt interval and can occasionally cause life threatening ventricular arrhythmias.
  • Hypokaleamia and hypomagnesaemia should be be corrected before sotalol is started
  • contra-indications = long QT syndrome and torsades
  • monitoring of ECG and electrolytes.
49
Q

Digoxin

A
  • cardiac glycosides
  • positive ionotrope and negative chronotrope

Dose
- Plasma concentration 0.8-1mcg
- dose of digoxin can be determined at ventricular rate at rest
- should not be allowed to fall <60bpm
- reduce dose by half if given with amiodarone, dronedarone or quinine

Toxicity
- toxicity ranges from 1.5-3mcg/L
- toxicity is increased with electrolyte disturbances like HYPOKALEAMIA
- symptoms SICK AND SLOW
BRADYCARDIA, HEART BLOCK
NAUSEA, VOMITING, ABDOMINAL PAIN AND DIARRHOEA
YELLOW VISION

Antidote
- antidote - digoxin specific antibody fragments - Digifab
- atropine sulfate can also be used to reverse the bradyarrythmias and ventricular arrhythmias

Monitoring
- plasma concentration - 6 hours after the dose is given
- serum electrolytes
- renal function

50
Q

Oral anticoagulants

A

Warfarin
DOACS

51
Q

Parenteral anticoagulants

A

Heparin unfractioned
LMWH

52
Q

Anti-platelet drugs

A

Examples - aspirin, clopidogrel, dipyridamole, prasugrel, ticagrelor.

High blood pressure needs to be controlled before aspirin is given

Dual anti-platelet increases risk of bleeding.

53
Q

Aspirin
- doses (suspected TIA, ACUTE ischaemic stroke, AF following a disabling i schematic stroke, ischaemic stroke in pts receiving anti-coagulation)
- Reye’s syndrome
- symptoms of overdose
- pregnancy

A
  • Dose
    Suspected TIA - 300mg daily until confirmed.
    Acute stroke - 300mg OD for 14 days
    AF Followinh ischemic stroke - 300mg OD for 14 days
    Ischaemic stroke in pts on anti-coags - 300mg OD, stop anticoagulat for a week and substitute with aspirin
  • Avoid in children under 16.
  • symptoms of salicylate poisoning are, hyperventilation, tinnitus, deafness, vasodilation and sweating. coma is uncommon but can happen in severe overdose.
  • pregnancy
    Avoid high doses in 3rd trimester. Interuterine growth restriction, delayed onset and duration of labour with increased blood loss, teratogenic.
54
Q

DOACS
- examples?
- how long do the effects last?
- reversal agents?
- MRHA alerts? (4)
- apixaban dose change
- edixaban dose change
- rivaroxaban dose change

A

Examples - Apixaban, dabigatran, edoxaban and rivaroxaban.

The anticoagulant effect lasts 12-24 hours. Therefore omitted or delayed doses could lead to reduction in anticoagulant effects.

Idarucizumab is the reversal agent for dabigatran.

Andexanet Alfa is the reversal agent for apixaban and rivaroxaban.

MHRA alerts
1. Contra-indicated in patients with major bleeding risk (current/recent GI ulcerations, malignant neoplasm @ high risk of bleeding, recent brain or spinal injury, recent surgery to brain, spine or eye, recent intracranial haemorrhage, oesophageal varcies, vascular aneurysm, or any vascular abnormalities)
2. Recurrent thrombotic events in patients with antiphospholipid syndrome (DOACS not recommended)
3. Reminder of bleeding risk and availability or reversal agent.
4. Monitoring during COVID-19 pandemic.
5. Avoid rivaroxaban in pts with prosthetic heart valves including patients who have undergone TAVR - Increased risk of all cause death and bleeding.

Apixaban - reduce to 2.5mg in pts
> 80age, weight < 60kg and crcl > 133micromol/L

Edoxaban - reduce dose to 30mg OD with concurrent ciclosporin, dronedarone, erythromycin, or ketoconazole.

Rivaroxaban - reduce dose to 15mg if crcl 15-49ml/minute.

55
Q

Heparins (unfractioned)

A

Also referred to as a standard.

  • Rapid anticoagulation
  • Shorter duration of action
  • preferred in patients with high risk of bleeding because the effects can be terminated quickly by stopping the infusion.

Preferred in patients with renal impairment.

Side effect-
1. Haemorrhage - sufficient to withdraw and rapid reversal with profaning sulfate.
2. Heparin induced thrombocytopenia - if suspected or confirmed… stop and use alternative anticoagulant. Ensure platelet count returns to normal range in those who require warfarin.
3. Hyperkaleamia - risk is higher in patients with diabetes, renal failure, acidosis, those taking potassium supplements. Risk increases with prolonged use.

Monitoring - 1. Plasma-Potassium concentration (if given for longer than 7 days) 2.platelet counts (if given for longer than 4 days)

56
Q

LMWH

A

Examples - dalteparin, enoxaparin, tinzaparin

  • longer duration of action the unfractioned heparin
  • lower risk of heparin induced thrombocytes
  • does not require anticoagulant monitoring

Preferred in pregnancy.

Side effect-
1. Haemorrhage - sufficient to withdraw and rapid reversal with profaning sulfate.
2. Heparin induced thrombocytopenia - if suspected or confirmed… stop and use alternative anticoagulant. Ensure platelet count returns to normal range in those who require warfarin.
3. Hyperkaleamia - risk is higher in patients with diabetes, renal failure, acidosis, those taking potassium supplements. Risk increases with prolonged use.

Monitoring - 1. Plasma-Potassium concentration (if given for longer than 7 days) 2.platelet counts (if given for longer than 4 days)

57
Q

Vitamin K antagonists
- examples?
- how long do they take to work?
- main adverse effect and what to do?

A

Examples - warfarin, acenocoumarol and phenindione.

Takes 48-72 hours for full effect to develop

Target INR = 2.5
For everything except recurrent DVT/PE (INR=3.5)

Duration for isolated calf-vein DVT = 6 weeks.

Adverse effect
- HAEMORRHAGE
What needs to be done?
1. Withdraw - check INR 2-3 days later.
2. Investigate the cause

Bleeding.. INR > 8.0 or 5 - 8.0
stop warfarin > give IV phytomenandione
Only restart if INR < 5.0.

INR 5 - 8.0 no bleeding
Withhold doses and reduce maintenance dose of warfarin.

58
Q

Warfarin
- important safety info (4)
- conception/contraception and pregnancy

A
  • Vitamin K antagonist

Important safety information
1. Acute illness can increase INR (COVID19)
2. Interactions with anti-vitals and antibacterial.
3. Stop warfarin before starting DOAC.
4. Side-effect of calciphylaxis - pts to report any painful skin rashes.

Conception/contraception and pregnancy
- dangers of teratogenicity
- risk of congenital malformation
- avoid in 1st and 3rd trimester - placental, fetal and neonatal haemorrhage.

59
Q

ACE inhibitors
When are ACEi initiated under supervision ?
The use of ACEi when someone is already on a diuretic?
What are they used in?
Cautioned?
Side-effects/ further information?
Monitoring?

A
  • Potassium supplements and potassium diuretics should be discontinued before introducing ACEi because of hyperkaleamia. However, low dose spironelactone is used in heart failure.
  • initiated under specialist supervision:-
    • Multiple or high dose diuretic therapy (80mg or more furosemide)
    • with hypovolaemia
    • hyponatreamia (130mmol/L or less)
    • hypotension (90mmHg or less)
    • pts with unstable heart failure
    • known renovascular disease
  • in some patients the diuretic therapy may need to be reduced or discontinued at least 24 hours before initiating. However, in heart failure may cause rebound pulmonary oedema.

AVOID IN SEVERE BILATERAL RENAL ARTERY STENOSIS

Used in
1. Heart failure
2. Hypertention
3. Diabetic nephropathy
4. Prevention of cardiovascular events
5. Acute coronary syndrome.

Caution - diabetes (may lower blood glucose)

Side-effects - angioedema and cough.
Further information - reports of cholestatic jaundice, hepatitis, hepatic necrosis or hepatic failure - discontinue if marked elevation of hepatic enzyme or jaundice occurs.

Monitoring
- renal function
- electrolytes (hyperkalaemia)

60
Q

ARBs
How are they different to ACEi?
What are they used in?

A
  • they do not inhibit the breakdown of bradykinin and other kinins so not likely to cause persistent dry cough.

Used in
1. Heart failure
2. Hypertention
3. Diabetic nephropathy
4. Prevention of cardiovascular events
5. Acute coronary syndrome.

61
Q

Beta-Blockers

A
62
Q

Calcium channel blockers

A
63
Q

Thiazide and related diuretics

A
64
Q

Hydrochlorothiazide

A
65
Q

Aldosterone antagonist

A
66
Q

Bile acid sequestrants
Eg colesevlam, colestyramine

A
67
Q

Ezetimibe

A

Inhibits the intestinal absorption of cholesterol

68
Q

Fibrates

A
69
Q

Statins

A
70
Q

Ranolazine

A
71
Q

Ivabradine

A
72
Q

Nicorandil

A
73
Q

Fibrinolytic drugs
Eg. Alteplase

A
74
Q

Nitrates

A
75
Q

Adrenaline

A
76
Q

Loop diuretics

A
77
Q

Types of AF

A

Proxymal - returns to sinus rhythum within 7 days
Non-proxymal - returns to sinus rhythm after 7 days
Permanent - does not return to sinus rhythm

78
Q

What is VENOUS THROMBOEMBOLISM

A

Deep vein thrombosis
Pulmonary embolism

79
Q

What is hospital acquired VTE?

A

VTE that occurs within 90 days of hospital admission. It is common and a preventable problem.

80
Q

Risk factors for VTE

A
  • surgery
  • trauma
  • immobile
  • malignancy
  • obesity
  • pregnancy or postpartum
  • inherited or acquired hypercoagulable states
  • hormonal therapy (contraceptives/HRT)
81
Q

Symptoms of DVT

A

Unilateral localised pain, swelling, tenderness, skin changes, vein distension.

82
Q

Pulmonary embolism - what is it and symptoms?

A

Occurs when a blood clot (usually from a DVT) travels in the blood to the lungs and obstructs blood flow.

Symptoms are shortness of breath, chest pain and haemoptysis.

83
Q

Methods of thromboprophylaxis?

A

2 types of thromboprophylaxis -
1. Mechanical
2. Pharmacological

Mechanical
- anti embolism stockings - worn day and night and calf pressure of 14-15mmHg
- intermittent pneumatic compression

84
Q

Who should not get anti-embolism stockings?

A
  • acute stroke
  • peripheral arterial disease
  • peripheral neuropathy
  • severe leg oedema
  • local conditions (gangrene or dermatitis)
85
Q

VTE prophylaxis in surgical patients
How to reduce the risk?
Which surgeries do you offer mechanical prophylaxis in?
Which surgery do you offer pharmacological prophylaxis?
How long is it used for?

A

To reduce the risk of VTE regional anaesthesia over general anaesthesia should be used.

Mechanical prophylaxis to be offered in
1. Pts with major trauma
2. Cranial surgery (30 days after surgery)
3. Abdominal surgery
4. Bariatric surgery
5. Thoracic surgery
6. Maxillofacial, ear, nose or throat surgery
7. Cardiac surgery
8. Elective spinal surgery (30 days)
(Continue until the patient is mobile or discharged from hospital)

Pharmacological prophylaxis should be considered in:-
1. General surgery (continue for upto 7 days or until mobile)
2. Orthopaedic surgery
3. Major cancer surgery (extend to 28 days)

For pharmacological prophylaxis LMWH is used.

In renal impairment heparin unfractioned is preferred.

86
Q

Which anticoagulant is used in pts with renal impairment?

A

Heparin unfractioned

87
Q

Thromboprophylaxis in pts undergoing elective hip replacement?

A
  • LMWH for 10 days followed by aspirin for further 28 days
  • LMWH for full 28 days + anti-embolism stockings
  • rivaroxiban

Alternatives are apixaban or dabigatran.

If contra-indicated then anti-embolism stockings until discharge.

88
Q

Patients undergoing elective knee replacement surgery?

A
  • low dose aspirin for 14 days
  • LMWH for 14 days + anti-embolism stockings
    Rivaroxaban

Alternatives - apixaban or dabigatran

Contra-indicated - intermittent pneumatic compression

89
Q

VTE prophylaxis in medical patients

A

Acutely ill patients and high risk

Pharmacological prophylaxis
- LMWH
- fondaparinux sodium
(for minimum 7 days)

Mechanical prophylaxis is an alternative of contra-indicated.

90
Q

Thromboprophylaxis in acute stroke

A

Mechanical prophylaxis with intermittent pneumatic compression is considered. Use needs to be started within 3 days and continued for 30 days or until mobile.

Anti-embolism stockings are unsuitable.

91
Q

Thromboprophylaxis in pregnancy

A

All pregnant women (in active labour)
Given birth
Miscarried
Termination of pregnancy during the past 6 weeks
________________________

  • LMWH
    Until no longer a risk or discharged
    _________________________

Start 4-8 hours after event unless contraindicated and then for a minimum of 7 days.

92
Q

How do you treat confirmed VTE or PE?

A

Before starting treatment do baseline tests:
- FBC
- renal function
- hepatic function
- prothrombin time
- activated partial thromboplastin time.

Treatment options
1. Apixaban or rivaroxiban
2. Unsuitable :-
- LMWH for 5 days followed by dabigatran or edoxaban
- LMWH for 5 days with vitamin K antagonist for 5 days or until INR is 2.0
Followed by vitamin K antagonist.

93
Q

Duration of anticoagulation following confirmed PE/VTE?

A

Provoked DVT/PE - treat for 3 months (3-6 month if it’s active cancer)

Unprovoked DVT/PE - consider continuing anticoagulation beyond 3 months (6 months for active cancer)

94
Q

What is used to treat DVT/PE in pregnancy?

A
  • LMWH
    Can also use elastic graduated compression stocking on the affected leg to help with pain and swelling.
95
Q

Anticoagulation before surgery

A

Elective surgery -
- stop 5 days before
- give phytomenandione the date before the surgery if the INR > 1.5
- resume warfarin the next day.

What if high risk of thromboembolism?
Can use bridging with LMWH. And stop the LMWH 24 hours before the surgery.

Emergency surgery
- DELAY for 6-12 hours and give Iv Phytomenandione.
- canNOT DELAY then give dried prothrombin complex alongside the IV phytomenandione.

96
Q

Combined anticoagulation and antiplatelet therapy?

A
  • keep the duration as small as possible
  • aspirin + warfarin > warfarin + clopidogrel (more risk of bleeding)
97
Q

Dabigatran
- what is it?
- MHRA alerts (4)

A
  • direct thrombin inhibitor.

MHRA ALERTS
1. Contra-indicated in patients with major bleeding risk (current/recent GI ulcerations, malignant neoplasm @ high risk of bleeding, recent brain or spinal injury, recent surgery to brain, spine or eye, recent intracranial haemorrhage, oesophageal varcies, vascular aneurysm, or any vascular abnormalities)
2. Recurrent thrombotic events in patients with antiphospholipid syndrome (DOACS not recommended)
3. Reminder of bleeding risk and availability or reversal agent.
4. Monitoring during COVID-19 pandemic.

98
Q

Vasodilators as antihypertensives
What happens if the patient is given these?
What do we add alongside to reduce the side effects?

A

Vasodilators are accompanied by increase cardiac output and tachycardia. The patient will also develop fluid retention. Because of this the patient should also be on a diuretic or on a beta- blocker

Examples
- hydralazine
- sodium nitroprusside - given IV infusion for severe hypertensive emergencies
- minoxidil

Pre-reg Material (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions